Unfortunately, normal plasma cells are not an accessible model to test the functional consequences of the uncommon KRAS exon-4 mutations, nor is it clear which MM cell lines would provide definitive answers to assess their transformative potential, since all display lesions that already affect RAS-dependent pathways. Here, KRAS is linked to Miyoshi myopathy.